• Join
  • Login
  • Contact

Search abstracts

Cardiovascular medicines: comparative costs and benefits

  • At: Dublin (Ireland) (2013)
  • Type: Poster
  • By: CARDONA, Mark (University of Malta, Pharmacy, Attard, Malta)
  • Co-author(s): Serracino-Inglott, Anthony (University of Malta, Attard, Malta)
    Zarb Adami, Maurice (University of Malta, Attard, Malta)
    Azzopardi, Lilian (University of Malta, Attard, Malta)
    Vella, John (University of Malta, Attard, Malta)
  • Abstract:


    : Cardiovascular disease (CVD) is the leading cause of death globally, accounting for an estimated 17.3 million people in 2008 and equating to a global cost of €863 million in 2010. This objectives of this study were to undertake a price comparison of originator and generic variants for CVD drugs and the estimate the cost to

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses